1987
DOI: 10.1152/ajpregu.1987.253.1.r142
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep

Abstract: The cytokines interleukin 1 (IL 1) and interferon (IFN) are immune response modifiers that are also pyrogenic and somnogenic. Tumor necrosis factor (TNF) (cachectin) is another pyrogenic monocyte product whose production can be elicited by somnogenic agents such as endotoxin. Human recombinant TNF (rTNF), therefore, was assayed for somnogenic activity. Intravenous (iv) or intracerebroventricular (ICV) injections of rTNF enhanced slow-wave sleep (SWS) and electroencephalographic slow-wave (0.5-4.0 Hz) activity.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

12
111
0
7

Year Published

1997
1997
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 148 publications
(130 citation statements)
references
References 0 publications
12
111
0
7
Order By: Relevance
“…Consistent with current results, they affect each other's production and inhibition of one attenuates the sleep induced by the other (Takahashi et al, 1999. Low doses of IL1β or TNFα enhance non rapid eye movement sleep (NREMS) (Kapas et al, 1992;Krueger et al, 1984;Shoham et al, 1987;Tobler et al, 1984). Conditions associated with increases in endogenous levels of IL1β or TNFα, e.g., time-of-day (Floyd and Krueger, 1997;Taishi et al, 1998), excessive food intake or infectious disease (Toth and Krueger, 1988) promote NREMS.…”
Section: Discussionsupporting
confidence: 73%
“…Consistent with current results, they affect each other's production and inhibition of one attenuates the sleep induced by the other (Takahashi et al, 1999. Low doses of IL1β or TNFα enhance non rapid eye movement sleep (NREMS) (Kapas et al, 1992;Krueger et al, 1984;Shoham et al, 1987;Tobler et al, 1984). Conditions associated with increases in endogenous levels of IL1β or TNFα, e.g., time-of-day (Floyd and Krueger, 1997;Taishi et al, 1998), excessive food intake or infectious disease (Toth and Krueger, 1988) promote NREMS.…”
Section: Discussionsupporting
confidence: 73%
“…The mechanisms through which cytokines influence delta power during NREMS are complex and not fully understood. Early studies (28,39,49,52) demonstrate that cytokines alter EEG parameters and that these effects depend on the dose, time, and route of administration. For example, central administration of TNF enhances delta power during NREM sleep (50,51), whereas intraperitoneal administration increases NREM sleep duration without a concomitant increase of EEG delta power (15,16,27,51).…”
Section: Discussionmentioning
confidence: 99%
“…IL-1β increases the amplitude of EEG slow waves during NREMS in rabbit and rat, but these changes are dependent on the dose and on the time of administration (Shoham et al, 1987;Opp et al, 1991). Whereas central administration of TNFα enhances slow wave oscillations during NREMS (Takahashi et al, 1996c(Takahashi et al, , 1997, intraperitoneal injection of TNFα increases NREMS duration without a concomitant increase of EEG delta power Kubota et al, 2002).…”
Section: Discussionmentioning
confidence: 99%